UPMC invests and expands services in Rome hospital
UPMC announced today it is investing in Salvator Mundi International Hospital, a private hospital near Rome's city center.
The Pittsburgh-headquartered medical system will also expand advanced cancer services and other specialized treatments at the hospital.
UPMC now owns a 50 percent stake in Salvator Mundi, which treats patients in central and southern Italy.
Rome International Hospital Management Srl (RIHM), which operates the facility, owns the other half.
“Given UPMC's long-standing and successful operations in Italy, we are excited about partnering with RIHM to bring more high-quality services to patients who currently are underserved by both private and public health care providers,” said Charles Bogosta, president of UPMC International.
The Rome hospital draws about 2,400 admissions and performs about 3,000 surgeries and procedures annually.
UPMC will lead the clinical operations of the 75-bed hospital, including designation of the medical director and chief operating officer.
The hospital joins UPMC's other Italian operations including radiotherapy center UPMC San Pietro FBF in Rome, transplant hospital ISMETT in Palermo, the UPMC Institute for Health at the Terme di Chianciano Spa in Chianciano Terme, an outpatient diagnostic and wellness center, and the planned Biomedical Research and Biotechnology Center in Carini.